Ulka N Vaishampayan

Ulka N Vaishampayan

UNVERIFIED PROFILE

Are you Ulka N Vaishampayan?   Register this Author

Register author
Ulka N Vaishampayan

Ulka N Vaishampayan

Publications by authors named "Ulka N Vaishampayan"

Are you Ulka N Vaishampayan?   Register this Author

59Publications

1983Reads

17Profile Views

Changing face of metastatic prostate cancer: the law of diminishing returns holds true.

Curr Opin Oncol 2017 Mar 18. Epub 2017 Mar 18.

Karmanos Cancer Institute/Wayne State University, Detroit, Michigan, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0000000000000370DOI Listing
March 2017

The Role of Nephrectomy for Kidney Cancer in the Era of Targeted and Immune Therapies.

Am Soc Clin Oncol Educ Book 2016 ;35:e16-20

From the Karmanos Cancer Institute, Wayne State University, Detroit, MI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_158977DOI Listing
January 2017

Nivolumab for Metastatic Renal Cell Carcinoma: Results of a Randomized Phase II Trial.

J Clin Oncol 2015 May 1;33(13):1430-7. Epub 2014 Dec 1.

Robert J. Motzer, Memorial Sloan-Kettering Cancer Center, New York; Saby George, Roswell Park Cancer Institute, Buffalo, NY; Brian I. Rini, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH; David F. McDermott, Beth Israel Deaconess Medical Center, Dana-Farber/Harvard Cancer Center, Boston, MA; Bruce G. Redman, University of Michigan Comprehensive Cancer Center, Ann Arbor; Ulka N. Vaishampayan, Karmanos Cancer Institute, Wayne State University, Detroit, MI; Timothy M. Kuzel, Northwestern University Feinberg School of Medicine, Chicago, IL; Michael R. Harrison, Duke University Medical Center, Durham, NC; Harry A. Drabkin, Medical University of South Carolina, Charleston, SC; Theodore F. Logan, Indiana University Simon Cancer Center, Indianapolis, IN; Kim A. Margolin, Stanford University, Stanford, CA; Elizabeth R. Plimack, Fox Chase Cancer Center, Philadelphia, PA; Alexandre M. Lambert, Bristol-Myers Squibb, Braine-l'Alleud, Belgium; Ian M. Waxman, Bristol-Myers Squibb, Princeton, NJ; and Hans J. Hammers, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.59.0703DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4806782PMC
May 2015

Sequences and combinations of multifaceted therapy in advanced prostate cancer.

Curr Opin Oncol 2015 May;27(3):201-8

aKarmanos Cancer Institute bDepartment of Oncology, Wayne State University, Detroit, Michigan, USA.

View Article

Download full-text PDF

Source
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/CCO.0000000000000187DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4477943PMC
May 2015

A phase II study of bevacizumab and high-dose interleukin-2 in patients with metastatic renal cell carcinoma: a Cytokine Working Group (CWG) study.

J Immunother 2013 Nov-Dec;36(9):490-5

*Dartmouth Hitchcock Medical Center, Lebanon, NH †Dana-Farber Cancer Institute, Harvard School of Public Health ∥Beth Israel Deaconess Medical Center ‡‡Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA ‡Vanderbilt University Medical Center, Nashville, TN §Loyola University Medical Center, Maywood, IL ¶Georgetown Lombardi Comprehensive Cancer Center, Washington, DC #St. Luke's Roosevelt Hospital Center, New York, NY **Earle A. Chiles Research Institute ††Providence Cancer Center, Portland, OR §§Department of Oncology, Wayne State University, Karmanos Cancer Institute, Detroit, MI ∥∥Division of Oncology, Department of Medicine, University of Washington, Seattle Cancer Care Alliance, Seattle, WA.

View Article

Download full-text PDF

Source
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/CJI.0000000000000003DOI Listing
June 2014

Development of cabozantinib for the treatment of prostate cancer.

Core Evid 2014 23;9:61-7. Epub 2014 Apr 23.

Department of Oncology, Wayne State University/Karmanos Cancer Institute, Detroit, MI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/CE.S48498DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4003147PMC
June 2014

Monoclonal antibodies in oncology therapeutics: present and future indications.

Expert Opin Biol Ther 2013 Feb 4;13(2):269-82. Epub 2013 Jan 4.

Wayne State University, Barbara Ann Karmanos Cancer Institute, Department of Oncology, Department of Medicine, 4 Hudson Webber Cancer Research Center, 4100 John R, Detroit, MI 48201, USA.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1517/14712598.2012.75
Publisher Site
http://dx.doi.org/10.1517/14712598.2012.758705DOI Listing
February 2013

Safety, efficacy, pharmacokinetics, and pharmacodynamics of the combination of sorafenib and tanespimycin.

Clin Cancer Res 2010 Jul 4;16(14):3795-804. Epub 2010 Jun 4.

Barbara Ann Karmanos Cancer Institute, Department of Medicine, Wayne State University, Detroit, Michigan 48201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-10-0503DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2909581PMC
July 2010

Satraplatin: leading the new generation of oral platinum agents.

Expert Opin Investig Drugs 2009 Nov;18(11):1787-97

Department of Medicine, Division of Hematology/Oncology, Wayne State University, Barbara Ann Karmanos Cancer Institute, Detroit, MI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/13543780903362437DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3856359PMC
November 2009

Phase II trial of capecitabine and weekly docetaxel for metastatic castrate resistant prostate cancer.

J Urol 2009 Jul 17;182(1):317-23. Epub 2009 May 17.

Division of Oncology, Department of Internal Medicine, Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, Michigan, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2009.02.105DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3869185PMC
July 2009

Nephrectomy in the management of metastatic osteosarcoma.

Clin Genitourin Cancer 2008 Sep;6(2):124-7

Department of Urology, Department of Medicine, Wayne State University/Karmanos Cancer Institute, Detroit, MI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CGC.2008.n.020DOI Listing
September 2008

Phase II trial of pegylated interferon and thalidomide in malignant metastatic melanoma.

Anticancer Drugs 2007 Nov;18(10):1221-6

Division of Oncology, Department of Medicine, Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, Michigan, USA.

View Article

Download full-text PDF

Source
https://insights.ovid.com/crossref?an=00001813-200711000-000
Publisher Site
http://dx.doi.org/10.1097/CAD.0b013e3282eea391DOI Listing
November 2007

Phase II trial of interferon and thalidomide in metastatic renal cell carcinoma.

Invest New Drugs 2007 Feb 26;25(1):69-75. Epub 2006 Aug 26.

Division of Oncology, Department of Medicine, Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-006-9005-8DOI Listing
February 2007

Racial disparity in outcomes of a clinical trial population with metastatic renal cell carcinoma.

Urology 2006 Aug;68(2):296-301

Division of Hematology/Oncology, Department of Internal Medicine, Wayne State University School of Medicine/Barbara Ann Karmanos Cancer Institute, Detroit, Michigan 48201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2006.02.036DOI Listing
August 2006

Phase II trial of carboplatin and paclitaxel in cisplatin-pretreated advanced transitional cell carcinoma: a Southwest Oncology Group study.

Cancer 2005 Oct;104(8):1627-32

Division of Hematology/Oncology, Department of Medicine, Wayne State University Medical Center, Detroit, Michigan 48201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.21370DOI Listing
October 2005